SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001016169-11-000008
Filing Date
2011-05-09
Accepted
2011-05-09 10:53:15
Documents
6
Period of Report
2011-03-31
Filing Date Changed
2011-05-09

Document Format Files

Seq Description Document Type Size
1 march10q.htm 10-Q 398207
2 ex10empl.htm EX-10.1 119980
3 ex31paul.htm EX-31.1 13159
4 ex31bob.htm EX-31.2 13287
5 e32paul.htm EX-32.1 7854
6 ex32bob.htm EX-32.2 7864
  Complete submission text file 0001016169-11-000008.txt   561662
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 11821840
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10